Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by XpertMycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube
2017 ◽
Vol 23
(8)
◽
pp. 1045-1052
◽
2016 ◽
Vol 5
(6)
◽
pp. 563-569
2001 ◽
Vol 46
(1)
◽
pp. 29-36
◽
Keyword(s):
2015 ◽
Vol 33
(5)
◽
pp. 122
◽
Keyword(s):
1997 ◽
Vol 35
(8)
◽
pp. 2022-2025
◽
2001 ◽
Vol 45
(6)
◽
pp. 1934-1936
◽